Nektar Therapeutics | Utile Per Azione





Eps Cambiamento Data
Agios Pharmaceuticals USD -1.86 0.08 2025-12
ALKERMES USD 0.29 0.2 2025-12
Alterity Therapeutics Limited AUD 0 0 2023-12
Amgen USD 5.29 0.35 2025-12
Baxter International USD 0.44 0.25 2025-12
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Cara Therapeutics USD -5.04 3.24 2024-12
Cipla INR 15.2 1.52 2025-12
Dr.Reddys Laboratories INR 14.52 2.98 2025-12
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD -0.15 0.18 2024-09
Exelixis USD 0.97 0.19 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Grifols EUR 0.29 0.03 2026-03
Halozyme Therapeutics USD -0.24 1.96 2025-12
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Ironwood Pharmaceuticals USD -0.01 0.25 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 0.27 0.84 2025-09
Merck USD 2.04 0.54 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 2.04 0.38 2025-09
Pfizer USD 0.66 0.21 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Takeda JPY 65.74 73.57 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Xencor USD -0.09 0.01 2025-12


Nektar Therapeutics Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.